Otros idiomas Genscript Biotech Corporation

Acciones

1548

KYG3825B1059

Biotecnología e investigación médica

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 09:08:09 12/02/2026			Variación 5 días	Varia. 1 de enero.
12,37 ^HKD	-3,21 %		-0,80 %	-0,40 %

22/01	Genscript Biotech: Asociada registra ventas por 555 millones de dólares en el cuarto trimestre con CARVYKTI	MT
15/10/25	GenScript: Legend Biotech Reporta Ventas de CARVYKTI por 524 Millones de Dólares en el Tercer Trimestre	MT

Otros idiomas

22/01	Genscript Biotech Associate Books $555 Million in Q4 CARVYKTI Sales
15/10/25	GenScript Associate Books $524 Million in Q3 CARVYKTI Sales
14/10/25	Genscript Biotech Receives 480 Million Yuan Payment Under Sub-License Contract
17/08/25	Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2025
08/08/25	GenScript Biotech Corporation Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology
22/07/25	Genscript Expects to Swing to H1 Profit
22/07/25	Genscript Biotech expects profit before tax of $175.4m-$204.6m in HY
22/07/25	Genscript Biotech Corporation Provides Group Earnings Guidance for the Six Months Ended June 30, 2025
17/07/25	GenScript Associate Books $439 Million in Q2 CARVYKTI Sales; Shares Gain 4%
10/07/25	US lawmakers renew concerns about GenScript's ties to China
30/06/25	Genscript Biotech Corporation's Zhenjiang ProBio Biotech Co., Limited and ProBio Nanjing Receives Payments of Approximately USD 213.8 Million Under the R&A Agreement
30/06/25	Genscript Biotech Units Receive Payment Under Sub-License Contract
12/06/25	Genscript Biotech Grants Over 7.4 Million Restricted Shares Under Award Scheme
04/06/25	Genscript Biotech Corporation Announces New 5-Year Survey Data for Carvykti in Cartitude-1 Study for Multiple Myeloma at 2025
04/06/25	Genscript Biotech's Myeloma Drug Shows Progression-Free Survival in One-Third of Patients During Study
29/05/25	Genscript Biotech Corporation Announces Board and Committee Changes, Effective 29 May 2025
16/04/25	Genscript Biotech Associate Logs $369 Million in Q1 Sales of CARVYKTI
09/04/25	Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide
09/04/25	Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs
19/03/25	GenScript Unveils Prime Editing Boost with the Broad Institute Deal
12/03/25	GenScript Biotech Corporation Reports FY 2024 Results
12/03/25	Genscript Biotech Swings to Profit in 2024; Shares Down 4%
12/03/25	Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024
11/03/25	Genscript Biotech Corporation Announces Board and Board Committee Changes
17/02/25	Genscript Biotech Expects Higher 2024 Net Profit

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas Genscript Biotech Corporation

Acciones

1548

KYG3825B1059

Biotecnología e investigación médica

Otros idiomas

Filtros